Treatment options are limited for patients with postherpetic neuralgia (PHN), a chronic pain disorder caused by reactivation of the varicella zoster virus. Topical application of capsaicin ...
“These data support our efforts to bring a new shingles vaccine to global markets,” stated George Simeon, Curevo’s Chief Executive Officer. “Though somewhat unsurprising, given amezosvatein also ...
Crisugabalin — an oral calcium channel alpha 2 delta-1 subunit ligand — was safe and well-tolerated at doses of 40 mg/d and 80 mg/d and significantly reduced pain scores in patients with ...
Interestingly, expert consensus regarding the benefits of antiviral therapy, [17] prior to the publication of the Cochrane Collaboration report, was that it: The benefits of vaccination will be ...